business
Hosted by STAT Brand Studio · business · EN
Catalysts in Science explores the ideas and leaders shaping the future of health care, medicine, and the life sciences. Scientists, executives, clinicians, and other experts discuss the breakthroughs, research, and decisions moving their fields forward. Episodes are produced by STAT Brand Studio as sponsored content.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
30%
Guest openness
Selective
Sign up to generate a grounded pitch for Catalysts in Science.
Signup to Generate a PitchCatalysts in Science explores the ideas and leaders shaping the future of health care, medicine, and the life sciences. Scientists, executives, clinicians, and other experts discuss the breakthroughs, research, and decisions moving their fields forward. Episodes are produced by STAT Brand Studio as sponsored content.
Recent episodes include "Fifteen years later, Undetectable = Untransmittable continues to shape HIV care" (23 July 2026, 7 minutes), "New approaches for cancer’s toughest challenges" (25 June 2026, 7 minutes), and "How unmet patient needs are shaping the next phase of cancer research" (16 April 2026, 7 minutes).
Catalysts in Science publishes roughly monthly, with episodes averaging 10 minutes across 17 episodes.
Booking probability for Catalysts in Science is 30%, and the host is rated Selective on guests. Catalysts in Science requires a Pod Score of 80 or higher. Catalysts in Science's contact route on record: verified email.
The strongest fits for Catalysts in Science are Scientific Research & Development. Catalysts in Science has a business audience.
Catalysts in Science is a business podcast with 17 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Catalysts in Science
Fifteen years after the HIV Prevention Trials Network (HPTN) 052 study changed the understanding of HIV transmission, its influence continues to extend far beyond the clinic. In this conversation, Jared Baeten of Gilead...
Catalysts in Science
Advances in oncology are creating new opportunities to deliver more personalized care for patients. In this sponsored conversation, Dr. Mika Kakefuda Derynck, Senior Vice President and Therapeutic Area Head of Oncology...
Catalysts in Science
<p>Oncology leaders Jackson Egen of Gilead Sciences and Priti Hegde of Kite, a Gilead company, discuss how unmet patient needs are shaping the next phase of cancer research. They explore how Gilead and Kite are...
Catalysts in Science
<p>Drug pricing reforms were meant to protect patients — but they may also be reshaping where innovation happens. In this interview, John Stanford of Incubate explains how MFN price controls and regulatory uncertainty...
Catalysts in Science
<p>At the 2026 JPM Conference in San Francisco, Astellas President and CEO Naoki Okamura spoke with STAT Brand Studio Editor Jesse McQuarters about the company’s strategy and long-term vision as it enters an important...
Catalysts in Science
<p>People living with asthma understand that their environment affects their health, but they’re often left without the tools, guidance, or support to fully act on that knowledge. In this virtual event, Chiesi unveils...
Catalysts in Science
<p>In this collaborative episode of The Nucleus, Dr. John Overton, vice president and chief sequencing officer at Regeneron Genetics Center (RGC), joins STAT Brand Studio’s Jesse McQuarters to explore how integrating...
Catalysts in Science
<p> What does it take to transform the outlook for patients facing some of the most difficult cancers? Dr. Dietmar Berger, Chief Medical Officer at Gilead Sciences, shares how the company is tackling urgent needs in...
Catalysts in Science
<p>Biosimilars are driving down drug costs, expanding access to critical treatments, and creating space for future innovation. In this episode, Linda Choi MacDonald, EVP and Global Head of Commercial at Samsung Bioepis...
Catalysts in Science
<p>The sudden passing of Dr. Stephen Harrison in 2024 marked the loss of a visionary liver disease researcher and compassionate advocate. His legacy lives on through a new fellowship program that aims to educate and...
Catalysts in Science
<p>What does it take to bring a new therapy from concept to commercialization? In this episode, STAT Brand Studio editor Jesse McQuarters speaks with Jerry Keybl, SVP for Biopharma Products and Strategy at Avantor...
Catalysts in Science
<p>New York City is investing over $1 billion to become a global leader in the life sciences — and at the heart of that mission is a commitment to infrastructure, innovation, and equity. In this episode, STAT Brand...
Catalysts in Science
<p>Puerto Rico is emerging as a key biopharma hub, offering advanced manufacturing capabilities, a highly skilled workforce, and significant cost advantages. In this conversation, OcyonBio CEO Robert Salcedo discusses...
Catalysts in Science
<p>Colorectal cancer remains the second leading cause of cancer deaths, with disparities in screening and care access posing major challenges. At the 2024 STAT Summit, Dr. Angie Nicholas and Dr. Fola May discussed how...
Catalysts in Science
<p>NYU Grossman School of Medicine is transforming medical education with an innovative three-year medical degree and tuition-free enrollment. Senior Associate Dean Joan Cangiarella, M.D., highlights the school's...
Catalysts in Science
<p>Molecular testing tools, including tumor sequencing and increasingly sensitive diagnostics, are leveling up oncology by enabling precise, personalized cancer treatment. Clinicians can now detect circulating tumor...
<p>As CEO of NYU Langone Health and dean of the Grossman School of Medicine, Dr. Robert Grossman leads a health system that excels in patient-oriented metrics, with a strategic eye toward the future. In this STAT Brand...
Recent guests on Catalysts in Science. Study who booked and why before you pitch.
Executive Director, Prism Group
Gilead
Kite
Gilead Sciences
PitchCentric classifies Catalysts in Science under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
